139 related articles for article (PubMed ID: 30520240)
41. MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot Study.
Alberts D; Pottier C; Smargiasso N; Baiwir D; Mazzucchelli G; Delvenne P; Kriegsmann M; Kazdal D; Warth A; De Pauw E; Longuespée R
Proteomics Clin Appl; 2018 Jan; 12(1):. PubMed ID: 28801933
[TBL] [Abstract][Full Text] [Related]
42. Tissue MALDI Mass Spectrometry Imaging (MALDI MSI) of Peptides.
Beine B; Diehl HC; Meyer HE; Henkel C
Methods Mol Biol; 2016; 1394():129-150. PubMed ID: 26700046
[TBL] [Abstract][Full Text] [Related]
43. MALDI mass spectrometry imaging of formalin-fixed paraffin-embedded tissues in clinical research.
Gorzolka K; Walch A
Histol Histopathol; 2014 Nov; 29(11):1365-76. PubMed ID: 24838644
[TBL] [Abstract][Full Text] [Related]
44. MALDI-imaging mass spectrometry on tissues.
Mainini V; Lalowski M; Gotsopoulos A; Bitsika V; Baumann M; Magni F
Methods Mol Biol; 2015; 1243():139-64. PubMed ID: 25384744
[TBL] [Abstract][Full Text] [Related]
45. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
Longuespée R; Gagnon H; Boyon C; Strupat K; Dauly C; Kerdraon O; Ighodaro A; Desmons A; Dupuis J; Wisztorski M; Vinatier D; Fournier I; Day R; Salzet M
Proteomics Clin Appl; 2013 Jun; 7(5-6):337-54. PubMed ID: 23589350
[TBL] [Abstract][Full Text] [Related]
46. Proteomic analysis of PAXgene-fixed tissues.
Ergin B; Meding S; Langer R; Kap M; Viertler C; Schott C; Ferch U; Riegman P; Zatloukal K; Walch A; Becker KF
J Proteome Res; 2010 Oct; 9(10):5188-96. PubMed ID: 20812734
[TBL] [Abstract][Full Text] [Related]
47. MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.
Bollwein C; Gonҫalves JPL; Utpatel K; Weichert W; Schwamborn K
Molecules; 2022 May; 27(11):. PubMed ID: 35684402
[TBL] [Abstract][Full Text] [Related]
48. MALDI imaging mass spectrometry of N-linked glycans on formalin-fixed paraffin-embedded murine kidney.
Gustafsson OJ; Briggs MT; Condina MR; Winderbaum LJ; Pelzing M; McColl SR; Everest-Dass AV; Packer NH; Hoffmann P
Anal Bioanal Chem; 2015 Mar; 407(8):2127-39. PubMed ID: 25434632
[TBL] [Abstract][Full Text] [Related]
49. 2D and 3D MALDI-imaging: conceptual strategies for visualization and data mining.
Thiele H; Heldmann S; Trede D; Strehlow J; Wirtz S; Dreher W; Berger J; Oetjen J; Kobarg JH; Fischer B; Maass P
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt A):117-37. PubMed ID: 23467008
[TBL] [Abstract][Full Text] [Related]
50. Strategies for managing multi-patient 3D mass spectrometry imaging data.
Vos DRN; Jansen I; Lucas M; Paine MRL; de Boer OJ; Meijer SL; Savci-Heijink CD; Marquering HA; de Bruin DM; Heeren RMA; Ellis SR; Balluff B
J Proteomics; 2019 Feb; 193():184-191. PubMed ID: 30343012
[TBL] [Abstract][Full Text] [Related]
51. Round robin study of formalin-fixed paraffin-embedded tissues in mass spectrometry imaging.
Buck A; Heijs B; Beine B; Schepers J; Cassese A; Heeren RMA; McDonnell LA; Henkel C; Walch A; Balluff B
Anal Bioanal Chem; 2018 Sep; 410(23):5969-5980. PubMed ID: 29968108
[TBL] [Abstract][Full Text] [Related]
52. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
[TBL] [Abstract][Full Text] [Related]
53. Using the Chemical Noise Background in MALDI Mass Spectrometry Imaging for Mass Alignment and Calibration.
Boskamp T; Lachmund D; Casadonte R; Hauberg-Lotte L; Kobarg JH; Kriegsmann J; Maass P
Anal Chem; 2020 Jan; 92(1):1301-1308. PubMed ID: 31793765
[TBL] [Abstract][Full Text] [Related]
54. MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting.
Stauber J; Lemaire R; Franck J; Bonnel D; Croix D; Day R; Wisztorski M; Fournier I; Salzet M
J Proteome Res; 2008 Mar; 7(3):969-78. PubMed ID: 18247558
[TBL] [Abstract][Full Text] [Related]
55. Polarity switching mass spectrometry imaging of healthy and cancerous hen ovarian tissue sections by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI).
Nazari M; Muddiman DC
Analyst; 2016 Jan; 141(2):595-605. PubMed ID: 26402586
[TBL] [Abstract][Full Text] [Related]
56. Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.
de Vega RG; Sanchez MLF; Eiro N; Vizoso FJ; Sperling M; Karst U; Medel AS
Anal Bioanal Chem; 2018 Jan; 410(3):913-922. PubMed ID: 28801789
[TBL] [Abstract][Full Text] [Related]
57. Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis.
Fata CR; Seeley EH; Desouki MM; Du L; Gwin K; Hanley KZ; Hecht JL; Jarboe EA; Liang SX; Parkash V; Quick CM; Zheng W; Shyr Y; Caprioli RM; Fadare O
Hum Pathol; 2015 Oct; 46(10):1427-36. PubMed ID: 26243671
[TBL] [Abstract][Full Text] [Related]
58. N-Glycan matrix-assisted laser desorption/ionization mass spectrometry imaging protocol for formalin-fixed paraffin-embedded tissues.
Briggs MT; Ho YY; Kaur G; Oehler MK; Everest-Dass AV; Packer NH; Hoffmann P
Rapid Commun Mass Spectrom; 2017 May; 31(10):825-841. PubMed ID: 28271569
[TBL] [Abstract][Full Text] [Related]
59. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
[TBL] [Abstract][Full Text] [Related]
60. MALDI IMS and Cancer Tissue Microarrays.
Casadonte R; Longuespée R; Kriegsmann J; Kriegsmann M
Adv Cancer Res; 2017; 134():173-200. PubMed ID: 28110650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
